225 related articles for article (PubMed ID: 29162828)
21. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
Jeong JH; Yook S; Lee H; Ahn CH; Lee DY; Byun Y
Biochem Biophys Res Commun; 2013 Apr; 433(4):513-8. PubMed ID: 23523788
[TBL] [Abstract][Full Text] [Related]
22. A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
Zhao SJ; Wang DH; Li YW; Han L; Xiao X; Ma M; Wan DC; Hong A; Ma Y
Int J Nanomedicine; 2017; 12():2143-2160. PubMed ID: 28356733
[TBL] [Abstract][Full Text] [Related]
23. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.
Wu HT; Ou HY; Hung HC; Su YC; Lu FH; Wu JS; Yang YC; Wu CL; Chang CJ
Diabetologia; 2016 Aug; 59(8):1732-42. PubMed ID: 27221093
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of hepatic expression and secretion of selenoprotein P by metformin.
Speckmann B; Sies H; Steinbrenner H
Biochem Biophys Res Commun; 2009 Sep; 387(1):158-63. PubMed ID: 19576170
[TBL] [Abstract][Full Text] [Related]
25. The relationship between selenoprotein P and glucose metabolism in experimental studies.
Mao J; Teng W
Nutrients; 2013 May; 5(6):1937-48. PubMed ID: 23760059
[TBL] [Abstract][Full Text] [Related]
26. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.
Zhou J; Xu G; Bai Z; Li K; Yan J; Li F; Ma S; Xu H; Huang K
Toxicol Appl Pharmacol; 2015 Dec; 289(3):409-18. PubMed ID: 26522834
[TBL] [Abstract][Full Text] [Related]
27. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.
Satin LS; Butler PC; Ha J; Sherman AS
Mol Aspects Med; 2015 Apr; 42():61-77. PubMed ID: 25637831
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction.
Speckmann B; Pinto A; Winter M; Förster I; Sies H; Steinbrenner H
Free Radic Biol Med; 2010 Sep; 49(5):777-85. PubMed ID: 20542496
[TBL] [Abstract][Full Text] [Related]
30. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
[TBL] [Abstract][Full Text] [Related]
31. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.
Fierabracci V; De Tata V; Pocai A; Novelli M; Barberà A; Masiello P
Endocrine; 2002 Nov; 19(2):177-84. PubMed ID: 12588048
[TBL] [Abstract][Full Text] [Related]
32. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
[TBL] [Abstract][Full Text] [Related]
33. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.
Toye AA; Lippiat JD; Proks P; Shimomura K; Bentley L; Hugill A; Mijat V; Goldsworthy M; Moir L; Haynes A; Quarterman J; Freeman HC; Ashcroft FM; Cox RD
Diabetologia; 2005 Apr; 48(4):675-86. PubMed ID: 15729571
[TBL] [Abstract][Full Text] [Related]
34. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
35. Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic beta-Cells and its role in promotion of insulin secretion and protection against diabetes.
Kobayashi M; Ohnishi H; Okazawa H; Murata Y; Hayashi Y; Kobayashi H; Kitamura T; Matozaki T
Endocrinology; 2008 Nov; 149(11):5662-9. PubMed ID: 18635660
[TBL] [Abstract][Full Text] [Related]
36. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.
Terauchi Y; Iwamoto K; Tamemoto H; Komeda K; Ishii C; Kanazawa Y; Asanuma N; Aizawa T; Akanuma Y; Yasuda K; Kodama T; Tobe K; Yazaki Y; Kadowaki T
J Clin Invest; 1997 Mar; 99(5):861-6. PubMed ID: 9062343
[TBL] [Abstract][Full Text] [Related]
37. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
[TBL] [Abstract][Full Text] [Related]
38. Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats.
Gheibi S; Bakhtiarzadeh F; Jeddi S; Farrokhfall K; Zardooz H; Ghasemi A
Nitric Oxide; 2017 Apr; 64():39-51. PubMed ID: 28089828
[TBL] [Abstract][Full Text] [Related]
39. Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More.
Tsutsumi R; Saito Y
Biol Pharm Bull; 2020; 43(3):366-374. PubMed ID: 32115498
[TBL] [Abstract][Full Text] [Related]
40. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells.
Gonzalez R; Reingold BK; Gao X; Gaidhu MP; Tsushima RG; Unniappan S
J Endocrinol; 2011 Mar; 208(3):R9-R16. PubMed ID: 21224288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
